+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diaveridine Market - Global Forecast 2025-2030- Product Image
Diaveridine Market - Global Forecast 2025-2030- Product Image
Sale

Diaveridine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082539
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers seeking to optimize therapeutic strategies for animal health can benefit from a comprehensive analysis of the evolving Diaveridine market. This report offers actionable insights into scientific advances, regulatory changes, and the dynamic shifts impacting supply and demand for diaveridine across veterinary sectors.

Market Snapshot: Diaveridine Market Growth and Forecast

The Diaveridine market grew from USD 255.38 million in 2024 to USD 280.17 million in 2025. It is expected to continue its trajectory at a CAGR of 9.44%, reaching USD 438.91 million by 2030. This growth is driven by technological innovation in formulations, evolving regulatory environments, and increasing demand across aquaculture, poultry, and livestock sectors. Strategic investments and emerging partnerships are shaping both supply chains and competitive positioning. Decision-makers can leverage these trends to navigate evolving market complexity and ensure sustainable business performance.

Scope & Segmentation

This research offers a structured segmentation analysis and regional perspective, ensuring full visibility into the key drivers shaping the Diaveridine landscape.

  • End Users: Aquaculture, Livestock Farms (including cattle, ruminants, swine), and Poultry Farms
  • Dosage Forms: Granules (with water dispersible granules), Injectable (solution, suspension), Tablets (film coated, uncoated)
  • Applications: Prevention, Treatment (early stage, late stage interventions)
  • Routes of Administration: Oral, Parenteral (intramuscular, intravenous, subcutaneous)
  • Distribution Channels: Direct Sales, Distributors (national, regional), Online Pharmacies
  • Regions: Americas (with focus areas such as United States, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Zoetis Inc., Elanco Animal Health Incorporated, Merck & Co., Inc., Ceva Santé Animale S.A., Huvepharma S.A., Zhejiang NHU Co., Ltd., Shandong Lukang Pharmaceutical Co., Ltd., Hebei Veyong Bio-Chem Pharmaceutical Co., Ltd., Hubei Longxiang Bio-Technology Co., Ltd., Wuhan Yuandai Biotechnology Co., Ltd.

Key Takeaways: Strategic Insights for Market Leadership

  • Diaveridine is increasingly valued for its synergistic efficacy in veterinary protocols, especially when combined with sulfonamides to address protozoal and bacterial infections in livestock and aquaculture.
  • Formulation innovation, including the adoption of water dispersible granules and advanced suspension systems, is expanding administration flexibility and improving therapeutic outcomes across diverse animal populations.
  • Heightened regulatory scrutiny around antimicrobial residues is prompting manufacturers to implement robust analytical testing and compliance mechanisms while driving industry-wide stewardship collaboration.
  • Digital solutions, from traceability to analytics-driven monitoring, are supporting quality assurance and real-time market adaptation for leading producers and distributors.
  • Regional differences in end-user priorities—ranging from precision agriculture adoption in the Americas to biosecurity improvements in the Middle East and Africa—highlight the necessity for product customization and tailored service delivery.
  • Competitive advantage is reinforced through investment in strategic alliances, local manufacturing, and next-generation combination therapies to support market resilience.

Tariff Impact and Supply Chain Realignment

Recent tariffs enacted in key markets have prompted manufacturers to reassess sourcing strategies and diversify supplier partnerships. This has resulted in a shift towards regional producers, strategic collaborations, and selective onshoring initiatives. Organizations are leveraging automation technologies and negotiating new distribution terms to maintain cost competitiveness and secure reliable market access despite evolving trade dynamics.

Methodology & Data Sources

The research integrates primary interviews with senior executives, veterinary professionals, and regulatory experts, supported by comprehensive secondary reviews of literature, patent databases, and official documentation. Analytical frameworks combine trend analysis, benchmarking, and mapping to validate insights and ensure a nuanced understanding of global Diaveridine market forces.

Why This Report Matters: Decision-Making Value for Diaveridine Market Stakeholders

  • Enables data-driven resource allocation by providing in-depth analysis of technological breakthroughs, regulatory changes, segmentation, and competitive strategies.
  • Supports effective risk mitigation through clear assessments of supply chain disruptions, tariff impacts, and compliance challenges specific to diaveridine applications.
  • Guides product strategy by identifying regional trends, user needs, and delivery innovations that drive downstream market differentiation.

Conclusion

This report equips industry leaders with credible intelligence to navigate technological, regulatory, and regional shifts in the Diaveridine market. By acting on these insights, organizations can sustain competitive advantage and capitalize on emerging opportunities within the evolving animal health sector.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising antimicrobial resistance concerns driving demand for diaveridine combination therapies in poultry production
5.2. Regulatory agencies accelerating approval processes for diaveridine-based veterinary medicines in emerging markets
5.3. Innovation in sustained-release diaveridine formulations improving compliance and efficacy in livestock treatments
5.4. Strategic collaborations between biotech firms and poultry producers to optimize diaveridine usage protocols
5.5. Shift towards integrated coccidiosis management strategies incorporating diaveridine and complementary health products
5.6. Supply chain disruptions and price volatility influencing global availability of diaveridine veterinary compounds
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Diaveridine Market, by End User
8.1. Introduction
8.2. Aquaculture
8.3. Livestock Farms
8.3.1. Cattle
8.3.2. Ruminants
8.3.3. Swine
8.4. Poultry Farms
9. Diaveridine Market, by Dosage Form
9.1. Introduction
9.2. Granules
9.2.1. Water Dispersible Granules
9.3. Injectable
9.3.1. Solution
9.3.2. Suspension
9.4. Tablets
9.4.1. Film Coated Tablets
9.4.2. Uncoated Tablets
10. Diaveridine Market, by Application
10.1. Introduction
10.2. Prevention
10.3. Treatment
10.3.1. Early Stage
10.3.2. Late Stage
11. Diaveridine Market, by Route Of Administration
11.1. Introduction
11.2. Oral
11.3. Parenteral
11.3.1. Intramuscular
11.3.2. Intravenous
11.3.3. Subcutaneous
12. Diaveridine Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.3.1. National
12.3.2. Regional
12.4. Online Pharmacies
13. Americas Diaveridine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Diaveridine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Diaveridine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Zoetis Inc.
16.3.2. Elanco Animal Health Incorporated
16.3.3. Merck & Co., Inc.
16.3.4. Ceva Santé Animale S.A.
16.3.5. Huvepharma S.A.
16.3.6. Zhejiang NHU Co., Ltd.
16.3.7. Shandong Lukang Pharmaceutical Co., Ltd.
16.3.8. Hebei Veyong Bio-Chem Pharmaceutical Co., Ltd.
16.3.9. Hubei Longxiang Bio-Technology Co., Ltd.
16.3.10. Wuhan Yuandai Biotechnology Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DIAVERIDINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DIAVERIDINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DIAVERIDINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DIAVERIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DIAVERIDINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DIAVERIDINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIAVERIDINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIAVERIDINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DIAVERIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DIAVERIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DIAVERIDINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DIAVERIDINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DIAVERIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DIAVERIDINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DIAVERIDINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DIAVERIDINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. DIAVERIDINE MARKET: RESEARCHAI
FIGURE 26. DIAVERIDINE MARKET: RESEARCHSTATISTICS
FIGURE 27. DIAVERIDINE MARKET: RESEARCHCONTACTS
FIGURE 28. DIAVERIDINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DIAVERIDINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIAVERIDINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DIAVERIDINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DIAVERIDINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DIAVERIDINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DIAVERIDINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DIAVERIDINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DIAVERIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DIAVERIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DIAVERIDINE MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DIAVERIDINE MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DIAVERIDINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DIAVERIDINE MARKET SIZE, BY CATTLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DIAVERIDINE MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DIAVERIDINE MARKET SIZE, BY RUMINANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DIAVERIDINE MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DIAVERIDINE MARKET SIZE, BY SWINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DIAVERIDINE MARKET SIZE, BY POULTRY FARMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DIAVERIDINE MARKET SIZE, BY POULTRY FARMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DIAVERIDINE MARKET SIZE, BY GRANULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DIAVERIDINE MARKET SIZE, BY GRANULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DIAVERIDINE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DIAVERIDINE MARKET SIZE, BY WATER DISPERSIBLE GRANULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DIAVERIDINE MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DIAVERIDINE MARKET SIZE, BY GRANULES, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DIAVERIDINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DIAVERIDINE MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DIAVERIDINE MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DIAVERIDINE MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DIAVERIDINE MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DIAVERIDINE MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DIAVERIDINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DIAVERIDINE MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DIAVERIDINE MARKET SIZE, BY FILM COATED TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DIAVERIDINE MARKET SIZE, BY FILM COATED TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DIAVERIDINE MARKET SIZE, BY UNCOATED TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DIAVERIDINE MARKET SIZE, BY UNCOATED TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DIAVERIDINE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DIAVERIDINE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DIAVERIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DIAVERIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DIAVERIDINE MARKET SIZE, BY PREVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DIAVERIDINE MARKET SIZE, BY PREVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DIAVERIDINE MARKET SIZE, BY TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DIAVERIDINE MARKET SIZE, BY TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DIAVERIDINE MARKET SIZE, BY EARLY STAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DIAVERIDINE MARKET SIZE, BY EARLY STAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DIAVERIDINE MARKET SIZE, BY LATE STAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DIAVERIDINE MARKET SIZE, BY LATE STAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DIAVERIDINE MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DIAVERIDINE MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DIAVERIDINE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DIAVERIDINE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DIAVERIDINE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DIAVERIDINE MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DIAVERIDINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DIAVERIDINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DIAVERIDINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DIAVERIDINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DIAVERIDINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DIAVERIDINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DIAVERIDINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DIAVERIDINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DIAVERIDINE MARKET SIZE, BY NATIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DIAVERIDINE MARKET SIZE, BY NATIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DIAVERIDINE MARKET SIZE, BY REGIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DIAVERIDINE MARKET SIZE, BY REGIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DIAVERIDINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DIAVERIDINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS DIAVERIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS DIAVERIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS DIAVERIDINE MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS DIAVERIDINE MARKET SIZE, BY GRANULES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS DIAVERIDINE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS DIAVERIDINE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS DIAVERIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS DIAVERIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS DIAVERIDINE MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS DIAVERIDINE MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS DIAVERIDINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS DIAVERIDINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES DIAVERIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES DIAVERIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES DIAVERIDINE MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES DIAVERIDINE MARKET SIZE, BY GRANULES, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES DIAVERIDINE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES DIAVERIDINE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES DIAVERIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES DIAVERIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES DIAVERIDINE MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES DIAVERIDINE MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES DIAVERIDINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES DIAVERIDINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA DIAVERIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. CANADA DIAVERIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. CANADA DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2018-2024 (USD MILLION)
TABLE 144. CANADA DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2025-2030 (USD MILLION)
TABLE 145. CANADA DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 146. CANADA DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 147. CANADA DIAVERIDINE MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
TABLE 148. CANADA DIAVERIDINE MARKET SIZE, BY GRANULES, 2025-2030 (USD MILLION)
TABLE 149. CANADA DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 150. CANADA DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 151. CANADA DIAVERIDINE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 152. CANADA DIAVERIDINE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 153. CANADA DIAVERIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. CANADA DIAVERIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. CANADA DIAVERIDINE MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 156. CANADA DIAVERIDINE MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 157. CANADA DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 160. CANADA DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 161. CANADA DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. CANADA DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. CANADA DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 164. CANADA DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO DIAVERIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. MEXICO DIAVERIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. MEXICO DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 170. MEXICO DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 171. MEXICO DIAVERIDINE MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
TABLE 172. MEXICO DIAVERIDINE MARKET SIZE, BY GRANULES, 2025-2030 (USD MILLION)
TABLE 173. MEXICO DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO DIAVERIDINE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO DIAVERIDINE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO DIAVERIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO DIAVERIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO DIAVERIDINE MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 180. MEXICO DIAVERIDINE MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 181. MEXICO DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. MEXICO DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. MEXICO DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 184. MEXICO DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 185. MEXICO DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. MEXICO DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. MEXICO DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL DIAVERIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL DIAVERIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL DIAVERIDINE MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL DIAVERIDINE MARKET SIZE, BY GRANULES, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL DIAVERIDINE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL DIAVERIDINE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL DIAVERIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL DIAVERIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL DIAVERIDINE MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL DIAVERIDINE MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA DIAVERIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA DIAVERIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA DIAVERIDINE MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA DIAVERIDINE MARKET SIZE, BY GRANULES, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA DIAVERIDINE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA DIAVERIDINE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA DIAVERIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA DIAVERIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA DIAVERIDINE MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA DIAVERIDINE MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY GRANULES, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA DIAVERIDINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY GRANULES, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 287. GERMANY DIAVERIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. GERMANY DIAVERIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. GERMANY DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2018-2024 (USD MILLION)
TABLE 290. GERMANY DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2025-2030 (USD MILLION)
TABLE 291. GERMANY DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 292. GERMANY DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 293. GERMANY DIAVERIDINE MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
TABLE 294. GERMANY DIAVERIDINE MARKET SIZE, BY GRANULES, 2025-2030 (USD MILLION)
TABLE 295. GERMANY DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 296. GERMANY DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 297. GERMANY DIAVERIDINE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 298. GERMANY DIAVERIDINE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 299. GERMANY DIAVERIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. GERMANY DIAVERIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. GERMANY DIAVERIDINE MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 302. GERMANY DIAVERIDINE MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 303. GERMANY DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. GERMANY DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. GERMANY DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 306. GERMANY DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 307. GERMANY DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 308. GERMANY DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 309. GERMANY DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 310. GERMANY DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 311. FRANCE DIAVERIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. FRANCE DIAVERIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. FRANCE DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2018-2024 (USD MILLION)
TABLE 314. FRANCE DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2025-2030 (USD MILLION)
TABLE 315. FRANCE DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 316. FRANCE DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 317. FRANCE DIAVERIDINE MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
TABLE 318. FRANCE DIAVERIDINE MARKET SIZE, BY GRANULES, 2025-2030 (USD MILLION)
TABLE 319. FRANCE DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 320. FRANCE DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 321. FRANCE DIAVERIDINE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 322. FRANCE DIAVERIDINE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 323. FRANCE DIAVERIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. FRANCE DIAVERIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. FRANCE DIAVERIDINE MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 326. FRANCE DIAVERIDINE MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 327. FRANCE DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 328. FRANCE DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 329. FRANCE DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 330. FRANCE DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 331. FRANCE DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. FRANCE DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. FRANCE DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 334. FRANCE DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 335. RUSSIA DIAVERIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. RUSSIA DIAVERIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. RUSSIA DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2018-2024 (USD MILLION)
TABLE 338. RUSSIA DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2025-2030 (USD MILLION)
TABLE 339. RUSSIA DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 340. RUSSIA DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA DIAVERIDINE MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA DIAVERIDINE MARKET SIZE, BY GRANULES, 2025-2030 (USD MILLION)
TABLE 343. RUSSIA DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 344. RUSSIA DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 345. RUSSIA DIAVERIDINE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 346. RUSSIA DIAVERIDINE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 347. RUSSIA DIAVERIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 348. RUSSIA DIAVERIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 349. RUSSIA DIAVERIDINE MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 350. RUSSIA DIAVERIDINE MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLION)
TABLE 351. RUSSIA DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 352. RUSSIA DIAVERIDINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 353. RUSSIA DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 354. RUSSIA DIAVERIDINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 355. RUSSIA DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 356. RUSSIA DIAVERIDINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 357. RUSSIA DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 358. RUSSIA DIAVERIDINE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 359. ITALY DIAVERIDINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 360. ITALY DIAVERIDINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 361. ITALY DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2018-2024 (USD MILLION)
TABLE 362. ITALY DIAVERIDINE MARKET SIZE, BY LIVESTOCK FARMS, 2025-2030 (USD MILLION)
TABLE 363. ITALY DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 364. ITALY DIAVERIDINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 365. ITALY DIAVERIDINE MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
TABLE 366. ITALY DIAVERIDINE MARKET SIZE, BY GRANULES, 2025-2030 (USD MILLION)
TABLE 367. ITALY DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 368. ITALY DIAVERIDINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 369. ITALY DIAVERIDINE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 370. ITALY DIAVERIDINE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 371. ITALY DIAVERIDINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 372. ITALY DIAVERIDINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 373. ITALY DIAVERIDINE MARKET SIZE, BY TREATMENT, 2018-2024 (USD MILLION)
TABLE 374. ITALY DIAVERIDINE MARKET SIZE, BY TREATMENT, 2025-2030 (USD MILLI

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Diaveridine market report include:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Ceva Santé Animale S.A.
  • Huvepharma S.A.
  • Zhejiang NHU Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Hebei Veyong Bio-Chem Pharmaceutical Co., Ltd.
  • Hubei Longxiang Bio-Technology Co., Ltd.
  • Wuhan Yuandai Biotechnology Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 280.17 Million
Forecasted Market Value ( USD ) by 2030 $ 438.91 Million
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Diaveridine (CAS 5355-16-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Diaveridine (CAS 5355-16-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Ethopabate Market - Global Forecast 2025-2030 - Product Image

Ethopabate Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Animal Drug Compounding Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Route Of Administration, By Dosage Form, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Animal Drug Compounding Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Route Of Administration, By Dosage Form, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
U.S. Animal Health Market Size, Share & Trends Analysis Report By Animal Type (Production Animal, Companion Animal), By Product, By Type Of Vaccine, By Disease, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. Animal Health Market Size, Share & Trends Analysis Report By Animal Type (Production Animal, Companion Animal), By Product, By Type Of Vaccine, By Disease, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • United States
From

About the Diaveridine Market

Diaveridine is an animal pharmaceutical drug used to treat a variety of bacterial infections in animals. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria. It is commonly used to treat respiratory, urinary, and gastrointestinal infections in animals. It is also used to treat certain skin infections. Diaveridine is available in both injectable and oral forms. Diaveridine is widely used in veterinary medicine, and is a popular choice for treating bacterial infections in animals. It is generally well-tolerated and has few side effects. It is also relatively inexpensive, making it a cost-effective treatment option. The Diaveridine market is an important part of the animal pharmaceuticals industry. It is a growing market, with many companies offering Diaveridine products. Some of the companies in the market include Bayer, Merck, Pfizer, Elanco, and Zoetis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.